p16Ink4a in melanocyte senescence and differentiation

Journal of the National Cancer Institute

Volumn 94, Issue 6, 2002, Pages 446-454

  Sviderskaya, Elena V ^a   Hill, Simon P ^a   Evans Whipp, Tracy J ^a   Chin, Lynda ^a   Orlow, Seth J ^a   Easty, David J ^a   Cheong, Sok Ching ^a   Beach, David ^a   DePinho, Ronald A ^a   Bennett, Dorothy C ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARF PROTEIN; BETA GALACTOSIDASE; COMPLEMENTARY DNA; GROWTH INHIBITOR; PROTEIN P16; RETROVIRUS VECTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL AGING; CELL CULTURE; CELL DEATH; CELL DIFFERENTIATION; CELL GROWTH; CELL IMMORTALIZATION; CELL LINE; CELL SIZE; CONTROLLED STUDY; FAMILIAL CANCER; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENETIC CODE; IMMUNOBLOTTING; MELANOCYTE; MELANOMA; MICROSCOPY; MOUSE; NONHUMAN; PIGMENTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CARCINOGENESIS; SPECTROPHOTOMETRY; STEM CELL; TUMOR SUPPRESSOR GENE;

EID: 0037139615     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/94.6.446     Document Type: Article

References (49)

1. The INK4a/ARF tumor suppressor: One gene-two products-two pathways
2. The p16INK4a/CDKN2A tumor suppressor and its relatives
3. The INK4A/ARF locus and its two gene products
4. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest
5. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
6. ARF
7. ARF, interacts with MDM2 and neutralizes MDM2's inhibition of p53
8. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2
9. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppressor pathways
10. INK4a tumor suppressor versus other INK4 family members during mouse development and aging
11. Role of the INK4a locus in tumor suppression and cell mortality
12. INK4A)
13. CIP1 in spontaneously immortalized human fibroblasts
14. INK4a
15. INK4a inactivation and telomerase activity are required to immortalize human epithelial cells
16. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus
17. Cellular senescence and cancer
18. Germline p16 mutations in familial melanoma
19. INK4 in benign and malignant melanocytic lesions
20. Complementation of hypopigmentation in p-mutant (pink-eyed dilution) mouse melanocytes by normal human P cDNA, and defective complementation by OCA2 mutant sequences
21. Phenotypic reversions at the W/Kit locus mediated by mitotic recombination in mice
22. Advanced mammalian gene transfer: High titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line
23. Rapid production of retroviruses for efficient gene delivery to mammalian cells using 293T cell-based systems
24. A biomarker that identifies senescent human cells in culture and in aging skin in vivo
25. Phenotypic rescue of mutant brown melanocytes by a retrovirus carrying a wild-type tyrosinase-related protein gene
26. Effects of the developmental colour mutations silver and recessive spotting on proliferation of diploid and immortal mouse melanocytes in culture
27. Cloned mouse melanocyte lines carrying the germline mutations albino and brown: Complementation in culture
28. WAF1/CIP1
29. Impaired growth and differentiation of diploid but not immortal melanoblasts from endothelin receptor B mutant (piebald) mice
30. Identification of two distinct regulatory regions adjacent to the human β-interferon gene
31. The Microphthalmia gene product interacts with the retinoblastoma protein in vitro and is a target for deregulation of melanocyte-specific transcription
32. Mitf from neural crest to melanoma: Signal transduction and transcription in the melanocyte lineage
33. p53 regulates myogenesis by triggering the differentiation activity of pRb
34. Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets
35. Genetics, development, and malignancy of melanocytes
36. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis
37. Arf predisposes mice to tumorigenesis
38. Ink4a confers susceptibility to metastatic melanoma in mice
39. Mutation and expression of the p53 gene in human malignant melanoma
40. Analysis of p53 in human cutaneous melanoma cell lines
41. The human melanocyte: A model system to study the complexity of cellular aging and transformation in non-fibroblastic cells
42. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens
43. RB regulates the stability and the apoptotic function of p53 via MDM2
44. Replicative senescence: Implications for in vivo aging and tumor suppression
45. Histochemical survey of the distribution of the epidermal melanoblasts and melanocytes in the mouse during fetal and postnatal periods
46. Biology of melanocytes
47. Local and systemic effects on the epidermal melanocyte population in UV-irradiated mouse skin
48. Regulation of E- and P-cadherin expression correlated with melanocyte migration and diversification
49. Cooperative effects of INK4a and ras in melanoma susceptibility in vivo